#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal cancer recurrent Orthostatic hypotension Mixed-type liposarcoma Castleman's disease Uveitis Pyruvate dehydrogenase complex deficiency Synovial sarcoma recurrent Fusarium infection Chondrosarcoma metastatic Chronic myeloid leukaemia (in remission) Chemical burn Red blood cell abnormality Lymphoma Liver abscess Kearns-Sayre syndrome More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Life with Disease Optic glioma – Diagnostics Pelizaeus-Merzbacher disease – Basic Information Myxofibrosarcoma Uterine leiomyosarcoma Aicardi-Goutieres syndrome – Treatment X-linked lymphoproliferative syndrome – Life with Disease KBG syndrome Haemophilia – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mitapivat Ro7247669 Tozinameran SELTOREXANT Fasudil Hydrochloride Vonafexor Opelconazole Bifikafusp Alfa Specific Nucleic Acid Sna-Ebv Gad20-209-Fsp-A2 Ide397 Dsimc Avibactam Clemizole Hydrochloride Alirocumab Sucrose Glycerol Ep0031 Gskvx000000008885 Mometasone More therapies…

    Learn about Your Condition

    Alcohol abuse Squamous cell carcinoma Carotid artery stenosis Large cell lung cancer stage 0 Skin candida Carcinoid syndrome Adrenocortical carcinoma Perthes disease Mixed dementia Haemorrhoids Skin angiosarcoma Klinefelter's syndrome Bladder cancer stage III Pulmonary vascular disorder Short-bowel syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dedifferentiated liposarcoma

  • Study of Trabectedin alone versus Trabectedin with tTF-NGR combination therapy in adults with metastatic or refractory soft tissue sarcoma who failed first-line treatment

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ttf-Ngr
    Germany

  • Study of Pemigatinib and Retifanlimab for Patients with Advanced Dedifferentiated Liposarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    • Liposarcoma
    • Liposarcoma metastatic
    Investigated Drugs:
    • Pemigatinib
    • Retifanlimab
    Denmark Norway Sweden

  • Study on the Effect of Chemotherapy with Ifosfamide, Dacarbazine, and Epirubicin Hydrochloride Before Surgery for Patients with High-Risk Retroperitoneal Sarcoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Dacarbazine
    • Ifosfamide
    Cyprus Czechia Denmark France Germany Italy +4

  • Study on the Effectiveness and Safety of INT230-6 (Vinblastine Sulfate, Cisplatin) for Adults with Metastatic Soft Tissue Sarcomas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    • Leiomyosarcoma
    • Malignant fibrous histiocytoma
    Investigated Drugs:
    • Pazopanib
    • Vinblastine Sulfate
    • Trabectedin
    France Germany Italy Poland Spain

  • Study on Pembrolizumab and Olaparib for Patients with Resectable Soft Tissue Sarcoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    • Malignant fibrous histiocytoma
    Investigated Drugs:
    • Olaparib
    • Pembrolizumab
    France

  • Study on the Safety and Tolerance of BI 907828 in Patients with Advanced Dedifferentiated Liposarcoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    Investigated Drugs:
    • (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
    Belgium Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!